Literature DB >> 21572340

Impairment of tight junctions and glucose transport in endothelial cells of human cerebral cavernous malformations.

Hannah Schneider1, Mariella Errede, Nils H Ulrich, Daniela Virgintino, Karl Frei, Helmut Bertalanffy.   

Abstract

Cerebral cavernous malformations (CCMs) often cause hemorrhages that can result in severe clinical manifestations, including hemiparesis and seizures. The underlying mechanisms of the aggressive behavior of CCMs are undetermined to date, but alterations of vascular matrix components may be involved. We compared the localization of the tight junction proteins (TJPs) in 12 CCM specimens and the expression of glucose transporter 1 (GLUT-1), which is sensitive to alterations in TJP levels, in 5 CCM specimens with those in 5 control temporal lobectomy specimens without CCM by immunofluorescence microscopy. The TJPs occludin, claudin-5, and zonula occludens ZO-1 were downregulated at intercellular contact sites and partly redistributed within the surrounding tissue in the CCM samples; there was also a marked reduction of GLUT-1 immunoreactivity compared with that in control specimens. Corresponding analysis using quantitative real-time reverse transcription polymerase chain reaction on 8 CCM and 8 control specimens revealed significant downregulation of mRNA expression of occludin, claudin-5, ZO-1, and GLUT-1. The altered expression and localization of the TJPs at interendothelial contact sites accompanied by a reduction of GLUT-1 expression in dilated CCM microvessels likely affect vascular matrix stability and may contribute to hemorrhages of CCMs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21572340     DOI: 10.1097/NEN.0b013e31821bc40e

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  18 in total

1.  Systems biology and proteomic analysis of cerebral cavernous malformation.

Authors:  Alexander R Edelmann; Sarah Schwartz-Baxter; Christopher F Dibble; Warren C Byrd; Jim Carlson; Ivandario Saldarriaga; Sompop Bencharit
Journal:  Expert Rev Proteomics       Date:  2014-03-31       Impact factor: 3.940

2.  Genome-Wide Sequencing Reveals MicroRNAs Downregulated in Cerebral Cavernous Malformations.

Authors:  Souvik Kar; Kiran Kumar Bali; Arpita Baisantry; Robert Geffers; Amir Samii; Helmut Bertalanffy
Journal:  J Mol Neurosci       Date:  2017-02-08       Impact factor: 3.444

Review 3.  STRIPAK complexes: structure, biological function, and involvement in human diseases.

Authors:  Juyeon Hwang; David C Pallas
Journal:  Int J Biochem Cell Biol       Date:  2013-12-11       Impact factor: 5.085

Review 4.  PTEN/PI3K/Akt/VEGF signaling and the cross talk to KRIT1, CCM2, and PDCD10 proteins in cerebral cavernous malformations.

Authors:  Souvik Kar; Amir Samii; Helmut Bertalanffy
Journal:  Neurosurg Rev       Date:  2014-11-19       Impact factor: 3.042

Review 5.  Cerebral cavernous malformation proteins at a glance.

Authors:  Kyle M Draheim; Oriana S Fisher; Titus J Boggon; David A Calderwood
Journal:  J Cell Sci       Date:  2014-01-30       Impact factor: 5.285

6.  Dynamic contrast-enhanced MRI evaluation of cerebral cavernous malformations.

Authors:  Blaine L Hart; Saeid Taheri; Gary A Rosenberg; Leslie A Morrison
Journal:  Transl Stroke Res       Date:  2013-09-21       Impact factor: 6.829

7.  PDCD10 (CCM3) regulates brain endothelial barrier integrity in cerebral cavernous malformation type 3: role of CCM3-ERK1/2-cortactin cross-talk.

Authors:  Svetlana M Stamatovic; Nikola Sladojevic; Richard F Keep; Anuska V Andjelkovic
Journal:  Acta Neuropathol       Date:  2015-09-18       Impact factor: 17.088

8.  Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth.

Authors:  Romuald Girard; Hussein A Zeineddine; Janne Koskimäki; Maged D Fam; Ying Cao; Changbin Shi; Thomas Moore; Rhonda Lightle; Agnieszka Stadnik; Kiranj Chaudagar; Sean Polster; Robert Shenkar; Ryan Duggan; David Leclerc; Kevin J Whitehead; Dean Y Li; Issam A Awad
Journal:  Circ Res       Date:  2018-05-02       Impact factor: 17.367

9.  PHACE syndrome is associated with intracranial cavernous malformations.

Authors:  Kimberly A Foster; William J Ares; Zachary J Tempel; Andrew A McCormick; Ashok Panigrahy; Lorelei J Grunwaldt; Stephanie Greene
Journal:  Childs Nerv Syst       Date:  2016-04-28       Impact factor: 1.475

Review 10.  Role of Delta-Notch signaling in cerebral cavernous malformations.

Authors:  Souvik Kar; Arpita Baisantry; Arya Nabavi; Helmut Bertalanffy
Journal:  Neurosurg Rev       Date:  2016-01-16       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.